Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Magnesium and Dexmedetomidine Combination Reduces Sodium Nitroprusside Requirement in Laparoscopic Pheochromocytoma

NCT05102058 is registered in ClinicalTrials.gov with Istanbul University as lead sponsor.

NCT NCT05102058
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05102058 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Magnesium and Dexmedetomidine Combination Reduces Sodium Nitroprusside Requirement in Laparoscopic Pheochromocytoma
Lead sponsor
Istanbul University
Phase
Observational
Overall status
Completed
Start date
January 1, 2011
Completion date
March 1, 2020
Enrollment
108 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

hemodynamic instability, phaeochromocytoma crisis